What is the recommended dosage of ibutilide (antiarrhythmic medication) for converting atrial fibrillation to a normal sinus rhythm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ibutilide Dosage for Atrial Fibrillation Conversion

The recommended dosage of ibutilide for converting atrial fibrillation to normal sinus rhythm is 1 mg IV administered over 10 minutes, followed by a second 1 mg dose after waiting for 10 minutes if the first dose is ineffective. 1

Standard Dosing Protocol

  • Initial dose: 1 mg IV administered over 10 minutes 1
  • Follow-up dose: If atrial fibrillation persists 10 minutes after completion of the first infusion, a second 1 mg dose should be administered over 10 minutes 1, 2
  • The maximum total dose should not exceed 2 mg 2

Efficacy and Timing

  • Conversion to normal sinus rhythm typically occurs within 30 minutes of starting the infusion in approximately 70% of patients who respond 2, 3
  • Ibutilide is more effective for atrial flutter (conversion rates 48-76%) than for atrial fibrillation (conversion rates 25-51%) 2, 4
  • Recent-onset arrhythmias (less than 30 days duration) respond better to ibutilide than chronic arrhythmias 2, 5

Safety Considerations and Monitoring

  • ECG and hemodynamic monitoring is mandatory during administration and for at least 4 hours afterward due to risk of QT prolongation and torsades de pointes 1
  • QT interval and T-U wave abnormalities should be closely monitored during and after administration 1
  • The risk of polymorphic ventricular tachycardia/torsades de pointes is approximately 3-4% of patients 1
  • Nonsustained ventricular tachycardia occurs in 2.7-6.7% of patients, while sustained polymorphic ventricular tachycardia occurs in approximately 1.7% 3, 5

Contraindications

Ibutilide should be avoided in patients with:

  • QT prolongation 1
  • Hypokalemia 1
  • Severe left ventricular hypertrophy 1
  • Low ejection fraction 1
  • Systolic blood pressure <100 mmHg 1
  • Recent acute coronary syndrome (within 30 days) 1
  • NYHA Class III and IV heart failure 1
  • Severe aortic stenosis 1

Special Populations

  • In elderly patients (≥65 years), standard dosing can be used with similar efficacy (54-63% conversion rate), but with careful monitoring for adverse effects 6
  • For post-cardiac surgery atrial fibrillation/flutter, doses of 0.5-1 mg have shown efficacy (42-44% for atrial fibrillation, 61-78% for atrial flutter) 2

Clinical Pearls

  • Patients should be adequately hydrated before ibutilide administration 1
  • Have emergency equipment readily available, including defibrillator and medications to treat potential arrhythmias 1
  • Ibutilide will slow the ventricular rate in addition to its cardioversion effects 1
  • The elimination half-life ranges from 2-12 hours, requiring continued monitoring after administration 3
  • In comparative studies, ibutilide has shown superior efficacy to procainamide and sotalol for conversion of both atrial fibrillation and flutter 3, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.